MLchartDataset catalogue

carboxyamidotriazole

Term · Oncology and biomedicine · MLC-T-ONC-001422

  1. An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors.

  2. An orally-active agent with potential antineoplastic activity. Carboxyamidotriazole binds to and inhibits non-voltage-operated Ca2+ channels, blocking both Ca2+ influx into cells and Ca2+ release from intracellular stores and resulting in the disruption of calcium channel-mediated signal transduction and inhibition of vascular endothelial growth factor (VEGF) signaling, endothelial proliferation, and angiogenesis. This agent may also inhibit tumor cell growth, invasion and metastasis.

Table 1. Record
IdentifierMLC-T-ONC-001422
FieldOncology and biomedicine
AbbreviationCAI
Synonymscarboxyamido-triazole; carboxyaminoimidazole
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-001422",
  "term": "carboxyamidotriazole",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An anticancer drug that belongs to the family of drugs called angiogenesis inhibitors.",
    "An orally-active agent with potential antineoplastic activity. Carboxyamidotriazole binds to and inhibits non-voltage-operated Ca2+ channels, blocking both Ca2+ influx into cells and Ca2+ release from intracellular stores and resulting in the disruption of calcium channel-mediated signal transduction and inhibition of vascular endothelial growth factor (VEGF) signaling, endothelial proliferation, and angiogenesis. This agent may also inhibit tumor cell growth, invasion and metastasis."
  ],
  "abbreviation": "CAI",
  "synonyms": [
    "carboxyamido-triazole",
    "carboxyaminoimidazole"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/carboxyamidotriazole/"
}

Record 4,210 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.